| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/04/2023 | 12.83% | Benchmark | $106 → $135 | Maintains | Buy |
| 06/14/2023 | — | Needham | Downgrades | Buy → Hold | |
| 05/12/2023 | -11.4% | Benchmark | → $106 | Reiterates | Buy → Buy |
| 05/12/2023 | -8.06% | Needham | → $110 | Reiterates | Buy → Buy |
| 04/21/2023 | -3.88% | Jefferies | → $115 | Initiates Coverage On | → Buy |
| 02/16/2023 | -11.4% | Benchmark | $100 → $106 | Maintains | Buy |
| 02/16/2023 | -8.06% | Needham | → $110 | Reiterates | → Buy |
| 02/14/2023 | -8.06% | Needham | $90 → $110 | Maintains | Buy |
| 11/04/2022 | -24.78% | Needham | $85 → $90 | Maintains | Buy |
| 10/07/2022 | -10.57% | B of A Securities | $130 → $107 | Maintains | Buy |
| 06/29/2022 | -3.88% | B of A Securities | $140 → $115 | Maintains | Buy |
| 05/13/2022 | 0.3% | Needham | $130 → $120 | Maintains | Buy |
| 02/25/2022 | 18.68% | Citigroup | $146 → $142 | Maintains | Buy |
| 02/25/2022 | 8.65% | Needham | $150 → $130 | Maintains | Buy |
| 11/17/2021 | 25.37% | Needham | $135 → $150 | Maintains | Buy |
| 11/05/2021 | 12.83% | Needham | $110 → $135 | Maintains | Buy |
| 07/14/2021 | -8.06% | Needham | $100 → $110 | Maintains | Buy |
| 05/05/2021 | -13.91% | Stifel | $81 → $103 | Upgrades | Hold → Buy |
| 04/21/2021 | -16.42% | Needham | $87 → $100 | Maintains | Buy |
| 02/09/2021 | -24.78% | Citigroup | → $90 | Initiates Coverage On | → Buy |
| 10/19/2020 | -45.67% | Needham | $60 → $65 | Maintains | Buy |
| 10/14/2020 | -45.67% | Benchmark | $63 → $65 | Maintains | Buy |
| 08/05/2020 | -47.34% | Benchmark | $50 → $63 | Maintains | Buy |
| 06/22/2020 | -59.88% | Stifel | → $48 | Downgrades | Buy → Hold |
| 05/15/2020 | -58.21% | Needham | $44 → $50 | Maintains | Buy |
| 01/21/2020 | -63.22% | Needham | $40 → $44 | Maintains | Buy |
| 11/08/2019 | -66.57% | Benchmark | $35 → $40 | Maintains | Buy |
| 09/27/2019 | -70.75% | Stifel | $33 → $35 | Maintains | Buy |
| 04/17/2019 | — | Needham | Initiates Coverage On | → Buy |
What is the target price for Nova (NVMI)?
The latest price target for Nova (NASDAQ: NVMI) was reported by Benchmark on August 4, 2023. The analyst firm set a price target for $135.00 expecting NVMI to rise to within 12 months (a possible 12.83% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nova (NVMI)?
The latest analyst rating for Nova (NASDAQ: NVMI) was provided by Benchmark, and Nova maintained their buy rating.
When is the next analyst rating going to be posted or updated for Nova (NVMI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nova, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nova was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
Is the Analyst Rating Nova (NVMI) correct?
While ratings are subjective and will change, the latest Nova (NVMI) rating was a maintained with a price target of $106.00 to $135.00. The current price Nova (NVMI) is trading at is $119.65, which is within the analyst's predicted range.